Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Insights into the polymorphism in HLA-DRA and its evolutionary relationship with HLA haplotypes.

Matern BM, Olieslagers TI, Voorter CEM, Groeneweg M, Tilanus MGJ.

HLA. 2019 Oct 16. doi: 10.1111/tan.13730. [Epub ahead of print]

PMID:
31617688
2.

Psychological Outcomes of a Cognitive Behavioral Therapy for Youth with Inflammatory Bowel Disease: Results of the HAPPY-IBD Randomized Controlled Trial at 6- and 12-Month Follow-Up.

Stapersma L, van den Brink G, van der Ende J, Szigethy EM, Groeneweg M, de Bruijne FH, Hillegers MHJ, Escher JC, Utens EMWJ.

J Clin Psychol Med Settings. 2019 Sep 10. doi: 10.1007/s10880-019-09649-9. [Epub ahead of print]

PMID:
31506853
3.

A Primer for Managed Care Residents: How to Conduct Research Using Live Medical and Pharmacy Claims Data.

Hung A, Gedey R, Groeneweg M, Jay M.

J Manag Care Spec Pharm. 2019 May;25(5):538-543. doi: 10.18553/jmcp.2019.25.5.538.

4.

Gut-directed hypnotherapy versus standard medical treatment for nausea in children with functional nausea or functional dyspepsia: protocol of a multicentre randomised trial.

Browne PD, den Hollander B, Speksnijder EM, van Wering HM, Tjon A Ten W, George EK, Groeneweg M, Bevers N, Wessels MMS, van den Berg MM, Goede J, Teklenburg-Roord STA, Frankenhuis C, Benninga MA, Vlieger AM.

BMJ Open. 2019 Apr 11;9(4):e024903. doi: 10.1136/bmjopen-2018-024903.

5.

Evaluation of the implementation of the 2012 ESPGHAN guideline of Coeliac disease in children: results of a retrospective study in the Netherlands.

Landman M, Theuns SDM, van Wering HM, Tramper G, van Ledden M, Rietveld E, Vd Lelij N, Groeneweg IK, Escher J, Groeneweg M.

Arch Dis Child. 2019 Mar 8. pii: archdischild-2018-316490. doi: 10.1136/archdischild-2018-316490. [Epub ahead of print] No abstract available.

PMID:
30850378
6.

Cannabis, a potential treatment option in pediatric IBD? Still a long way to go.

Halbmeijer N, Groeneweg M, De Ridder L.

Expert Rev Clin Pharmacol. 2019 Apr;12(4):355-361. doi: 10.1080/17512433.2019.1582330. Epub 2019 Feb 26. Review.

PMID:
30767696
7.

IL-10 signaling prevents gluten-dependent intraepithelial CD4+ cytotoxic T lymphocyte infiltration and epithelial damage in the small intestine.

Costes LMM, Lindenbergh-Kortleve DJ, van Berkel LA, Veenbergen S, Raatgeep HRC, Simons-Oosterhuis Y, van Haaften DH, Karrich JJ, Escher JC, Groeneweg M, Clausen BE, Cupedo T, Samsom JN.

Mucosal Immunol. 2019 Mar;12(2):479-490. doi: 10.1038/s41385-018-0118-0. Epub 2018 Dec 12.

PMID:
30542112
8.

A comprehensive overview of FCGR3A gene variability by full-length gene sequencing including the identification of V158F polymorphism.

Mahaweni NM, Olieslagers TI, Rivas IO, Molenbroeck SJJ, Groeneweg M, Bos GMJ, Tilanus MGJ, Voorter CEM, Wieten L.

Sci Rep. 2018 Oct 29;8(1):15983. doi: 10.1038/s41598-018-34258-1.

9.

Full-length extension of HLA allele sequences by HLA allele-specific hemizygous Sanger sequencing (SSBT).

Voorter CEM, Matern B, Tran TH, Fink A, Vidan-Jeras B, Montanic S, Fischer G, Fae I, de Santis D, Whidborne R, Andreani M, Testi M, Groeneweg M, Tilanus MGJ.

Hum Immunol. 2018 Nov;79(11):763-772. doi: 10.1016/j.humimm.2018.08.004. Epub 2018 Aug 11.

PMID:
30107213
10.

One-Year Outcomes of an Integrated Multiple Sclerosis Disease Management Program.

Groeneweg M, Forrester SH, Arnold B, Palazzo L, Zhu W, Yoon P, Scearce T.

J Manag Care Spec Pharm. 2018 May;24(5):458-463. doi: 10.18553/jmcp.2018.24.5.458.

11.

Saddlebags: A software interface for submitting full-length HLA allele sequences to the EMBL-ENA nucleotide database.

Matern BM, Groeneweg M, Voorter CEM, Tilanus MGJ.

HLA. 2018 Jan;91(1):29-35. doi: 10.1111/tan.13179.

PMID:
29160623
12.

Attention Deficit Hyperactivity Disorder and Functional Defecation Disorders in Children.

Kuizenga-Wessel S, Koppen IJN, Vriesman MH, Di Lorenzo C, van Dijk M, Beelen MLR, Groeneweg M, Stoffelsen RJ, Benninga MA.

J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):244-249. doi: 10.1097/MPG.0000000000001695.

PMID:
28742722
13.

The identification of celiac disease in asymptomatic children: the Generation R Study.

Jansen M, van Zelm M, Groeneweg M, Jaddoe V, Dik W, Schreurs M, Hooijkaas H, Moll H, Escher J.

J Gastroenterol. 2018 Mar;53(3):377-386. doi: 10.1007/s00535-017-1354-x. Epub 2017 Jun 6.

14.

Polymorphism at residue 156 of the new HLA-A*02:683 allele suggests immunological relevance.

Duygu B, Matern BM, Groeneweg M, Voorter CEM, Tilanus MGJ.

HLA. 2017 Aug;90(2):107-109. doi: 10.1111/tan.13059. Epub 2017 May 28.

PMID:
28556601
15.

Leukocyte Overexpression of Intracellular NAMPT Attenuates Atherosclerosis by Regulating PPARγ-Dependent Monocyte Differentiation and Function.

Bermudez B, Dahl TB, Medina I, Groeneweg M, Holm S, Montserrat-de la Paz S, Rousch M, Otten J, Herias V, Varela LM, Ranheim T, Yndestad A, Ortega-Gomez A, Abia R, Nagy L, Aukrust P, Muriana FJG, Halvorsen B, Biessen EAL.

Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1157-1167. doi: 10.1161/ATVBAHA.116.308187. Epub 2017 Apr 13.

PMID:
28408371
16.

Home-Based Hypnotherapy Self-exercises vs Individual Hypnotherapy With a Therapist for Treatment of Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, or Functional Abdominal Pain Syndrome: A Randomized Clinical Trial.

Rutten JMTM, Vlieger AM, Frankenhuis C, George EK, Groeneweg M, Norbruis OF, Tjon A Ten W, van Wering HM, Dijkgraaf MGW, Merkus MP, Benninga MA.

JAMA Pediatr. 2017 May 1;171(5):470-477. doi: 10.1001/jamapediatrics.2017.0091.

PMID:
28346581
17.

New insights in HLA-E polymorphism by refined analysis of the full-length gene.

Olieslagers TI, Voorter CE, Groeneweg M, Xu Y, Wieten L, Tilanus MG.

HLA. 2017 Mar;89(3):143-149. doi: 10.1111/tan.12965. Epub 2017 Jan 27.

PMID:
28127896
18.

The role of gene polymorphism in HLA class I splicing.

Voorter CE, Gerritsen KE, Groeneweg M, Wieten L, Tilanus MG.

Int J Immunogenet. 2016 Apr;43(2):65-78. doi: 10.1111/iji.12256. Epub 2016 Feb 27. Review.

PMID:
26920492
19.

Uncommon HLA alleles identified by hemizygous ultra-high Sanger sequencing: haplotype associations and reconsideration of their assignment in the Common and Well-Documented catalogue.

Voorter CE, Groeneweg M, Groeneveld L, Tilanus MG.

Hum Immunol. 2016 Feb;77(2):184-90. doi: 10.1016/j.humimm.2015.11.016. Epub 2015 Nov 30.

PMID:
26610902
20.

Minimum information for reporting next generation sequence genotyping (MIRING): Guidelines for reporting HLA and KIR genotyping via next generation sequencing.

Mack SJ, Milius RP, Gifford BD, Sauter J, Hofmann J, Osoegawa K, Robinson J, Groeneweg M, Turenchalk GS, Adai A, Holcomb C, Rozemuller EH, Penning MT, Heuer ML, Wang C, Salit ML, Schmidt AH, Parham PR, Müller C, Hague T, Fischer G, Fernandez-Viňa M, Hollenbach JA, Norman PJ, Maiers M.

Hum Immunol. 2015 Dec;76(12):954-62. doi: 10.1016/j.humimm.2015.09.011. Epub 2015 Sep 25.

21.

Full-length HLA-DRB1 coding sequences generated by a hemizygous RNA-SBT approach.

Gerritsen KE, Groeneweg M, Meertens CM, Voorter CE, Tilanus MG.

Tissue Antigens. 2015 Nov;86(5):333-42. doi: 10.1111/tan.12654. Epub 2015 Sep 23.

PMID:
26396036
22.

Features of a new full length HLA allele: A*02:455.

Crijns VB, Groeneweg M, Schouten HC, Voorter CE, Tilanus MG.

Tissue Antigens. 2015 Jul;86(1):53-5. doi: 10.1111/tan.12579. Epub 2015 May 11.

PMID:
25959797
23.

An improved and validated RNA HLA class I SBT approach for obtaining full length coding sequences.

Gerritsen KE, Olieslagers TI, Groeneweg M, Voorter CE, Tilanus MG.

Tissue Antigens. 2014 Nov;84(5):450-8. doi: 10.1111/tan.12436. Epub 2014 Sep 23.

PMID:
25251784
24.

The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity?

Schellekens J, Vanderlocht J, Groeneweg M, Voorter CE, Wieten L, Gelens MA, van Duijnhoven EM, van Heurn LW, Christiaans MH, Tilanus MG.

Transpl Immunol. 2014 Oct;31(4):213-8. doi: 10.1016/j.trim.2014.09.002. Epub 2014 Sep 21. Review.

PMID:
25240735
25.

Human buccal epithelium acquires microbial hyporesponsiveness at birth, a role for secretory leukocyte protease inhibitor.

Menckeberg CL, Hol J, Simons-Oosterhuis Y, Raatgeep HR, de Ruiter LF, Lindenbergh-Kortleve DJ, Korteland-van Male AM, El Aidy S, van Lierop PP, Kleerebezem M, Groeneweg M, Kraal G, Elink-Schuurman BE, de Jongste JC, Nieuwenhuis EE, Samsom JN.

Gut. 2015 Jun;64(6):884-93. doi: 10.1136/gutjnl-2013-306149. Epub 2014 Jul 23.

PMID:
25056659
26.

Gut-directed hypnotherapy in children with irritable bowel syndrome or functional abdominal pain (syndrome): a randomized controlled trial on self exercises at home using CD versus individual therapy by qualified therapists.

Rutten JM, Vlieger AM, Frankenhuis C, George EK, Groeneweg M, Norbruis OF, Tjon a Ten W, Van Wering H, Dijkgraaf MG, Merkus MP, Benninga MA.

BMC Pediatr. 2014 Jun 4;14:140. doi: 10.1186/1471-2431-14-140.

27.

Allorecognition of HLA-DP by CD4+ T cells is affected by polymorphism in its alpha chain.

Lauterbach N, Crivello P, Wieten L, Zito L, Groeneweg M, Voorter CE, Fleischhauer K, Tilanus MG.

Mol Immunol. 2014 May;59(1):19-29. doi: 10.1016/j.molimm.2013.12.006. Epub 2014 Jan 22.

PMID:
24462895
28.

Allele and haplotype frequencies of HLA-DPA1 and -DPB1 in the population of Guadeloupe.

Voorter CE, Groeneweg M, Joannis MO, Meertens C, Agis F, Tilanus MG.

Tissue Antigens. 2014 Mar;83(3):147-53. doi: 10.1111/tan.12271. Epub 2014 Jan 10.

PMID:
24405442
29.

HLA frequencies and associations in cystic fibrosis.

Adriaanse MP, Vreugdenhil AC, Groeneweg M, Brüggenwirth HT, Castelijns SJ, van der Ent CK, Voorter CE, Tilanus MG.

Tissue Antigens. 2014 Jan;83(1):27-31. doi: 10.1111/tan.12265.

PMID:
24355005
30.

Increased production of interleukin-21, but not interleukin-17A, in the small intestine characterizes pediatric celiac disease.

van Leeuwen MA, Lindenbergh-Kortleve DJ, Raatgeep HC, de Ruiter LF, de Krijger RR, Groeneweg M, Escher JC, Samsom JN.

Mucosal Immunol. 2013 Nov;6(6):1202-13. doi: 10.1038/mi.2013.19. Epub 2013 Apr 10.

PMID:
23571506
31.

Full-length HLA-DPB1 diversity in multiple alleles of individuals from Caucasian, Black, or Oriental origin.

Lauterbach N, Voorter CE, Stallinga CM, Groeneweg M, Wieten L, Tilanus MG.

Tissue Antigens. 2012 Mar;79(3):165-73. doi: 10.1111/j.1399-0039.2011.01834.x. Epub 2012 Jan 9.

PMID:
22224408
32.

Plasma water as a diagnostic tool in the assessment of dehydration in children with acute gastroenteritis.

Plaisier A, Maingay-de Groof F, Mast-Harwig R, Kalkman PM, Wulkan RW, Verwers R, Neele M, Hop WC, Groeneweg M.

Eur J Pediatr. 2010 Jul;169(7):883-6. doi: 10.1007/s00431-010-1140-8. Epub 2010 Feb 2.

PMID:
20127111
33.

Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro.

Schapira K, Burkly LC, Zheng TS, Wu P, Groeneweg M, Rousch M, Kockx MM, Daemen MJ, Heeneman S.

Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2021-7. doi: 10.1161/ATVBAHA.109.195040. Epub 2009 Sep 17.

PMID:
19762780
34.

Chronic hereditary pancreatitis in a girl with a serine protease inhibitor kazal type I (SPINK-1) gene mutation and a coxsackie type B5 infection.

Groeneweg M, Poley JW, Dansen M, Brinkman JG, Escher JC, Nieuwenhuis EE.

Pediatr Infect Dis J. 2009 Feb;28(2):169-70. doi: 10.1097/INF.0b013e318193e7e4. No abstract available.

PMID:
19106771
35.

Modification of LDL with oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (oxPAPC) results in a novel form of minimally modified LDL that modulates gene expression in macrophages.

Groeneweg M, Vergouwe MN, Scheffer PG, Vermue HP, Sollewijn Gelpke MD, Sijbers AM, Leitinger N, Hofker MH, de Winther MP.

Biochim Biophys Acta. 2008 Jun-Jul;1781(6-7):336-43. doi: 10.1016/j.bbalip.2008.04.016. Epub 2008 May 10. No abstract available.

PMID:
18534202
36.

Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis.

Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, Cleutjens JP, van den Akker LH, Corvol P, Wouters BG, Daemen MJ, Bijnens AP.

J Am Coll Cardiol. 2008 Apr 1;51(13):1258-65. doi: 10.1016/j.jacc.2007.12.025.

37.

Psychosocial co-morbidity affects treatment outcome in children with fecal incontinence.

van Everdingen-Faasen EQ, Gerritsen BJ, Mulder PG, Fliers EA, Groeneweg M.

Eur J Pediatr. 2008 Sep;167(9):985-9. Epub 2007 Oct 19.

PMID:
17952465
38.

The clinical effect of a new infant formula in term infants with constipation: a double-blind, randomized cross-over trial.

Bongers ME, de Lorijn F, Reitsma JB, Groeneweg M, Taminiau JA, Benninga MA.

Nutr J. 2007 Apr 11;6:8.

39.

Species-specific functioning of the Pseudomonas XcpQ secretin: role for the C-terminal homology domain and lipopolysaccharide.

Bitter W, van Boxtel R, Groeneweg M, Carballo PS, Zähringer U, Tommassen J, Koster M.

J Bacteriol. 2007 Apr;189(8):2967-75. Epub 2007 Feb 2.

40.

Lipopolysaccharide-induced gene expression in murine macrophages is enhanced by prior exposure to oxLDL.

Groeneweg M, Kanters E, Vergouwe MN, Duerink H, Kraal G, Hofker MH, de Winther MP.

J Lipid Res. 2006 Oct;47(10):2259-67. Epub 2006 Jul 13.

41.

[Acute abdominal pain as the first sign of Henoch-Schönlein purpura; a hidden diagnosis in the absence of purpura].

van der Boon F, Groeneweg M.

Ned Tijdschr Geneeskd. 2005 Nov 5;149(45):2522-6. Dutch.

PMID:
16304891
42.
43.

Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years.

ter Borg PC, Hollemans M, Van Buuren HR, Vleggaar FP, Groeneweg M, Hop WC, Laméris JS.

Radiology. 2004 May;231(2):537-45. Epub 2004 Mar 24.

PMID:
15044746
44.

[Two children with severe recurrent infections and the X-linked hyper-IgM syndrome].

Groeneweg M, Hartwig NG, Poerink-Stockschläder AB, Schweizer JJ, Bijleveld CM, Bredius RG.

Ned Tijdschr Geneeskd. 2003 May 24;147(21):1024-8. Dutch.

PMID:
12811975
45.

[From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome].

Groeneweg M, Lankester AC, Bredius RG.

Ned Tijdschr Geneeskd. 2003 May 24;147(21):1009-11. Review. Dutch.

PMID:
12811971
46.

Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?

Quero Guillén JC, Groeneweg M, Jiménez Sáenz M, Schalm SW, Herrerías Gutiérrez JM.

Rev Esp Enferm Dig. 2002 Sep;94(9):544-57. Review. English, Spanish.

PMID:
12587235
47.

The prognostic significance of subclinical hepatic encephalopathy.

Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, Schalm SW.

Am J Gastroenterol. 2000 Aug;95(8):2029-34.

PMID:
10950053
48.

Screening of subclinical hepatic encephalopathy.

Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW.

J Hepatol. 2000 May;32(5):748-53.

PMID:
10845661
49.

Subclinical hepatic encephalopathy impairs daily functioning.

Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, Schalm SW.

Hepatology. 1998 Jul;28(1):45-9.

PMID:
9657095
50.

Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study.

Gyr K, Meier R, Häussler J, Boulétreau P, Fleig WE, Gatta A, Holstege A, Pomier-Layrargues G, Schalm SW, Groeneweg M, Scollo-Lavizzari G, Ventura E, Zeneroli ML, Williams R, Yoo Y, Amrein R.

Gut. 1996 Aug;39(2):319-24.

Supplemental Content

Loading ...
Support Center